Tag: Immunotherapy
BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act
The biotech industry recently realized its 300th IPO since the Jumpstart Our Business Startups (JOBS) …
Curing Cancer: Advancements and What is Yet to Come
Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …
A Poignant Election Day Comeback
On Election Day, a day of underdogs and upsets in American politics, Representative Mark DeSaulnier …
WSJ: A Piece of the Immunotherapy Puzzle Solved
Just two weeks ago, the New York Times published a series of articles deeming immunotherapy …
ICYMI: NYT Chronicles Advances in Cancer Landscape Due to Immunotherapy
This week, the New York Times published a series of articles titled Cell Wars which explores …
The Power of Innovation
Today’s “Fox and Friends” included an informative segment about the staggering advances being made in …
T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets
New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …
Excerpts From Top Ten Current Science Trends Talk
For the opening day of BIO 2014, BioTech Primer delivered a talk on the Top …